Personalis, Inc. financial data

Symbol
PSNL on Nasdaq
Industry
Services-Medical Laboratories
Location
6600 Dumbarton Circle, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 456 % +1.73%
Debt-to-equity 47.8 % -3.57%
Return On Equity -54 % +19%
Return On Assets -36.5 % +18%
Operating Margin -80.7 % +46.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.3M shares +69.9%
Common Stock, Shares, Outstanding 85.2M shares +68.7%
Entity Public Float 71.6B USD -21%
Weighted Average Number of Shares Outstanding, Basic 59.3M shares +23%
Weighted Average Number of Shares Outstanding, Diluted 59.3M shares +23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 84.6M USD +15.2%
Cost of Revenue 57.8M USD +4.55%
Research and Development Expense 48.9M USD -24.5%
Costs and Expenses 153M USD -16.6%
Operating Income (Loss) -68.3M USD +37.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -81.3M USD +24.9%
Income Tax Expense (Benefit) 18K USD -78.3%
Net Income (Loss) Attributable to Parent -81.3M USD +24.9%
Earnings Per Share, Basic -1.37 USD/shares +39.1%
Earnings Per Share, Diluted -1.37 USD/shares +39.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.4M USD +60.4%
Accounts Receivable, after Allowance for Credit Loss, Current 8.14M USD -54.1%
Assets, Current 203M USD +38.3%
Property, Plant and Equipment, Net 48.3M USD -15.8%
Operating Lease, Right-of-Use Asset 16.5M USD -7.84%
Other Assets, Noncurrent 2.53M USD -19.5%
Assets 270M USD +20.1%
Accounts Payable, Current 6.4M USD -57.1%
Employee-related Liabilities, Current 8.54M USD -33.3%
Accrued Liabilities, Current 1.47M USD -25.5%
Contract with Customer, Liability, Current 3.1M USD -5.72%
Liabilities, Current 31.1M USD -34.1%
Contract with Customer, Liability, Noncurrent 150K USD
Operating Lease, Liability, Noncurrent 34.9M USD -8.97%
Other Liabilities, Noncurrent 1.3M USD -74.8%
Liabilities 67.3M USD -29.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23K USD +89.6%
Retained Earnings (Accumulated Deficit) -550M USD -17.3%
Stockholders' Equity Attributable to Parent 203M USD +56.8%
Liabilities and Equity 270M USD +20.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.4M USD -29.6%
Net Cash Provided by (Used in) Financing Activities 1.13M USD
Net Cash Provided by (Used in) Investing Activities 6.3M USD -54.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.2M shares +68.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13M USD -565%
Deferred Tax Assets, Valuation Allowance 162M USD +11.6%
Deferred Tax Assets, Gross 166M USD +10.8%
Operating Lease, Liability 42.6M USD -7.6%
Payments to Acquire Property, Plant, and Equipment 104K USD -97.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.1M USD +24.6%
Lessee, Operating Lease, Liability, to be Paid 70.5M USD -10.3%
Property, Plant and Equipment, Gross 94.3M USD -0.76%
Operating Lease, Liability, Current 7.7M USD -0.84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.23M USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.06M USD -0.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.19M USD -0.57%
Deferred Tax Assets, Operating Loss Carryforwards 94.2M USD +12.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.58M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.22M USD -27.5%
Operating Lease, Payments 2M USD +150%
Depreciation, Depletion and Amortization 10.9M USD -3.14%
Deferred Tax Assets, Net of Valuation Allowance 4.58M USD -12%
Share-based Payment Arrangement, Expense 10.7M USD -23.9%
Interest Expense 24K USD -78.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%